FOR MOUNJARO SOURCE: U.S
Weight loss results vary significantly by specific medication and dose: Semaglutide 2.4 mg (Wegovy): Clinical trials (STEP program) showed average weight reductions of 1517% at 68 weeks Tirzepatide (Zepbound): SURMOUNT trials demonstrated weight reductions of 1522% at 72 weeks, with results varying between populations with and without diabetes Liraglutide 3 mg (Saxenda): Typically produces 510% weight loss over 56 weeks The rate of weight loss is not linear
1,2,5 Importantly, treatment with retatrutide not only resulted in robust weight reduction, but also in clear improvements in assessed cardiometabolic health measures, concluded Jastreboff, according to the release
GLP-1 agonists and blood pressure: a review of the evidence
For snacks, you can eat apple slices with almond butter
EMS workers face similar patterns, with the additional challenge of frequent emergency response that produces irregular meals and high stress